Home › Squamous Cell Carcinoma ng Esophagus
Pag-aaral pangklinika para sa Squamous Cell Carcinoma ng Esophagus na nagre-recruit sa U.S.
35 pag-aaral para sa Squamous Cell Carcinoma ng Esophagus ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Arlington, VA16 pag-aaral
- Nashville, TN13 pag-aaral
- Houston, TX13 pag-aaral
- Los Angeles, CA12 pag-aaral
- Baldwin Park, CA10 pag-aaral
- New York City, NY9 pag-aaral
- West Valley City, UT7 pag-aaral
- San Antonio, TX7 pag-aaral
- Dallas, TX6 pag-aaral
- Orlando, FL6 pag-aaral
- Santa Monica, CA6 pag-aaral
- Queens, NY6 pag-aaral
- Austin, TX5 pag-aaral
- St. Louis, MO5 pag-aaral
- Boston, MA5 pag-aaral
- Irvine, CA5 pag-aaral
- Cleveland, OH5 pag-aaral
- Detroit, MI5 pag-aaral
- Fort Worth, TX5 pag-aaral
- Grand Rapids, MI5 pag-aaral
- Portland, OR4 pag-aaral
- Durham, NC4 pag-aaral
- Atlanta, GA4 pag-aaral
- Chicago, IL4 pag-aaral
- Pittsburgh, PA4 pag-aaral
- San Francisco, CA4 pag-aaral
- Rochester, MN3 pag-aaral
- Omaha, NE3 pag-aaral
- Fullerton, CA3 pag-aaral
- Orange, CA3 pag-aaral
- Seattle, WA3 pag-aaral
- Bridgeport, CT3 pag-aaral
- Philadelphia, PA3 pag-aaral
- New Haven, CT3 pag-aaral
- Irving, TX3 pag-aaral
- Coral Springs, FL3 pag-aaral
- Las Vegas, NV3 pag-aaral
- Greenville, SC3 pag-aaral
- Sarasota, FL3 pag-aaral
- Plantation, FL3 pag-aaral
Ayos sa estado
- Arizona7 pag-aaral
- California26 pag-aaral
- Colorado3 pag-aaral
- Connecticut4 pag-aaral
- Florida12 pag-aaral
- Georgia4 pag-aaral
- Illinois6 pag-aaral
- Massachusetts5 pag-aaral
- Michigan11 pag-aaral
- Minnesota5 pag-aaral
- Missouri6 pag-aaral
- Nebraska3 pag-aaral
- Nevada3 pag-aaral
- New Jersey6 pag-aaral
- New York15 pag-aaral
- North Carolina4 pag-aaral
- Ohio9 pag-aaral
- Oregon4 pag-aaral
- Pennsylvania8 pag-aaral
- South Carolina3 pag-aaral
- Tennessee13 pag-aaral
- Texas20 pag-aaral
- Utah7 pag-aaral
- Virginia16 pag-aaral
- Washington6 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06780111A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07405151A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07503808A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07090499CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07909031Study of XB010 in Subjects With Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06545331A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07109726A Study of MGC026 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06242470A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06747585A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06644781A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07730021A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT05914116A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT07554521Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT06084481A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT05563766A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT05319730Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06265285177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07189871A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07085091A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277413Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07229313A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07217171Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06535607A Study of IDP-001 in Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07602842Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.